Bernd O. Evert

4.3k total citations · 1 hit paper
49 papers, 3.3k citations indexed

About

Bernd O. Evert is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Bernd O. Evert has authored 49 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 31 papers in Cellular and Molecular Neuroscience and 8 papers in Neurology. Recurrent topics in Bernd O. Evert's work include Genetic Neurodegenerative Diseases (24 papers), Mitochondrial Function and Pathology (20 papers) and Ubiquitin and proteasome pathways (9 papers). Bernd O. Evert is often cited by papers focused on Genetic Neurodegenerative Diseases (24 papers), Mitochondrial Function and Pathology (20 papers) and Ubiquitin and proteasome pathways (9 papers). Bernd O. Evert collaborates with scholars based in Germany, Netherlands and United States. Bernd O. Evert's co-authors include Ullrich Wüllner, Thomas Klockgether, Ina Schmitt, Michel Eichelbaum, Péter Breuer, David C. Rubinsztein, Zdenek Berger, Brinda Ravikumar, Cahir J. O’Kane and Benjamin R. Underwood and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Bernd O. Evert

48 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rapamycin alleviates toxicity of different aggregate-prone proteins

2005 532 citations Zdenek Berger, Brinda Ravikumar et al. Human Molecular Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bernd O. Evert Germany	30	2.0k	1.3k	588	533	448	49	3.3k
Yasuhide Mitsumoto Japan	34	1.4k 0.7×	632 0.5×	418 0.7×	274 0.5×	380 0.8×	89	3.0k
Christoph Ullmer Switzerland	29	1.8k 0.9×	1.0k 0.8×	407 0.7×	277 0.5×	340 0.8×	69	3.8k
Tiziana Borsello Italy	31	2.1k 1.1×	1.2k 0.9×	1.5k 2.6×	272 0.5×	248 0.6×	82	4.1k
Santiago Ambrosio Spain	28	1.1k 0.6×	876 0.7×	353 0.6×	771 1.4×	320 0.7×	76	2.6k
Irina G. Stavrovskaya United States	26	1.7k 0.8×	1.1k 0.8×	780 1.3×	832 1.6×	241 0.5×	35	3.4k
Elena Alberdi Spain	38	1.6k 0.8×	1.4k 1.0×	1.0k 1.8×	296 0.6×	242 0.5×	71	4.6k
Antonella Scorziello Italy	34	2.2k 1.1×	1.2k 0.9×	601 1.0×	295 0.6×	294 0.7×	90	3.7k
Michelle Aarts Canada	19	1.7k 0.9×	1.4k 1.1×	427 0.7×	255 0.5×	211 0.5×	25	3.4k
Youming Lu China	35	2.4k 1.2×	1.5k 1.1×	758 1.3×	251 0.5×	179 0.4×	76	4.3k
Shirley E. Poduslo United States	28	2.4k 1.2×	1.1k 0.8×	1.2k 2.0×	351 0.7×	94 0.2×	74	4.4k

Countries citing papers authored by Bernd O. Evert

Since Specialization

Citations

This map shows the geographic impact of Bernd O. Evert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernd O. Evert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernd O. Evert more than expected).

Fields of papers citing papers by Bernd O. Evert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernd O. Evert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernd O. Evert. The network helps show where Bernd O. Evert may publish in the future.

Co-authorship network of co-authors of Bernd O. Evert

This figure shows the co-authorship network connecting the top 25 collaborators of Bernd O. Evert. A scholar is included among the top collaborators of Bernd O. Evert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernd O. Evert. Bernd O. Evert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Evert, Bernd O., et al.. (2024). The Alpha-Synuclein Gene (SNCA) is a Genomic Target of Methyl-CpG Binding Protein 2 (MeCP2)—Implications for Parkinson’s Disease and Rett Syndrome. Molecular Neurobiology. 61(10). 7830–7844. 7 indexed citations

Evert, Bernd O., Benedikt Pregler, Hannah A. Strobel, et al.. (2024). Tonabersat enhances temozolomide‐mediated cytotoxicity in glioblastoma by disrupting intercellular connectivity through connexin 43 inhibition. Molecular Oncology. 19(3). 878–898. 1 indexed citations

Evert, Bernd O., et al.. (2024). Spinocerebellar Ataxia Type 3 Pathophysiology—Implications for Translational Research and Clinical Studies. International Journal of Molecular Sciences. 25(7). 3984–3984. 2 indexed citations

Barrón‐Cabrera, Elisa, Abhay Narayan Singh, Roel C. Janssens, et al.. (2023). ATXN3 controls DNA replication and transcription by regulating chromatin structure. Nucleic Acids Research. 51(11). 5396–5413. 10 indexed citations

Breuer, Péter, Anna‐Laura Potthoff, Matthias Schneider, et al.. (2023). Downregulation of MGMT expression by targeted editing of DNA methylation enhances temozolomide sensitivity in glioblastoma. Neoplasia. 44. 100929–100929. 17 indexed citations

Krauß, Sybille & Bernd O. Evert. (2019). The Role of MicroRNAs in Spinocerebellar Ataxia Type 3. Journal of Molecular Biology. 431(9). 1729–1742. 10 indexed citations

Bengesser, Susanne, Eva Z. Reininghaus, Nina Lackner, et al.. (2016). Is the molecular clock ticking differently in bipolar disorder? Methylation analysis of the clock gene ARNTL. The World Journal of Biological Psychiatry. 19(sup2). S21–S29. 32 indexed citations

Breuer, Péter, Sybille Krauß, Katrin Zimmermann, et al.. (2011). FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3. Human Molecular Genetics. 20(15). 2928–2941. 85 indexed citations

Breuer, Péter, et al.. (2009). CK2-dependent phosphorylation determines cellular localization and stability of ataxin-3. Human Molecular Genetics. 18(17). 3334–3343. 78 indexed citations

10.

Evert, Bernd O., et al.. (2008). Different methylation of the TNF-alpha promoter in cortex and substantia nigra: Implications for selective neuronal vulnerability. Neurobiology of Disease. 32(3). 521–527. 92 indexed citations

11.

Klotz, Luisa, Indra Dani, Frank Edenhofer, et al.. (2007). Peroxisome Proliferator-Activated Receptor γ Control of Dendritic Cell Function Contributes to Development of CD4+ T Cell Anergy. The Journal of Immunology. 178(4). 2122–2131. 103 indexed citations

12.

Sastre, Magdalena, Ilse Dewachter, Steffen Roßner, et al.. (2006). Nonsteroidal anti-inflammatory drugs repress β-secretase gene promoter activity by the activation of PPARγ. Proceedings of the National Academy of Sciences. 103(2). 443–448. 321 indexed citations

13.

Evert, Bernd O., Ana Vieira‐Saecker, Rob A. I. de Vos, et al.. (2006). Ataxin-3 Represses Transcription via Chromatin Binding, Interaction with Histone Deacetylase 3, and Histone Deacetylation. Journal of Neuroscience. 26(44). 11474–11486. 125 indexed citations

14.

Jeub, Monika, Martin Herbst, Alexander Spauschus, et al.. (2006). Potassium channel dysfunction and depolarized resting membrane potential in a cell model of SCA3. Experimental Neurology. 201(1). 182–192. 18 indexed citations

15.

Schröder, Rolf, Giles D. Watts, Sarju Mehta, et al.. (2005). Mutant valosin‐containing protein causes a novel type of frontotemporal dementia. Annals of Neurology. 57(3). 457–461. 124 indexed citations

16.

Cong, Shuyan, Barry A. Pepers, Bernd O. Evert, et al.. (2005). Mutant huntingtin represses CBP, but not p300, by binding and protein degradation. Molecular and Cellular Neuroscience. 30(1). 12–23. 91 indexed citations

17.

Berger, Zdenek, Brinda Ravikumar, Fiona M. Menzies, et al.. (2005). Rapamycin alleviates toxicity of different aggregate-prone proteins. Human Molecular Genetics. 15(3). 433–442. 532 indexed citations breakdown →

18.

Seyfried, Jan, et al.. (2003). Gene dosage-dependent effects of bcl-2 expression on cellular survival and redox status. Free Radical Biology and Medicine. 34(12). 1517–1530. 14 indexed citations

19.

Evert, Bernd O., Ullrich Wüllner, & Thomas Klockgether. (2000). Cell death in polyglutamine diseases. Cell and Tissue Research. 301(1). 189–204. 60 indexed citations

20.

Evert, Bernd O., Ernst‐Ulrich Griese, & Michel Eichelbaum. (1994). Cloning and sequencing of a new non-functional CYP2D6 allele: Deletion of T1795 in exon 3 generates a premature stop codon. Pharmacogenetics. 4(5). 271–274. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact